Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | EVP, Engineering | September 28, 2021 | September 30, 2021 |
| Sight Sciences, Inc.SGHT · Entity 5537 | EVP, Operations & R&D | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 28, 2021 · Filed September 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,735 |
Reported balance
After 2021-09-28 transaction · row 1
1 source rowRow 1 · 2021-09-28 · Exercise / conversion · Acquired 12,945 · Balance 69,735 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2022-03-27 | Direct | 0 |
Reported balance
After 2021-09-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-28 · Exercise / conversion · Disposed 12,945 · Balance 0 F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 842 |
Reported balance
Holding disclosure · report date 2021-09-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 842 |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012.
Sight Sciences, Inc.
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 261,990 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 2,988 · Balance 261,990 F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · derivative · entry 8 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 5,000 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 200 | $200.47 | $40,094.60 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,576 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F6 · price: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $200.39 to $200.52 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,200 | $199.25 | $239,099.04 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,776 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F5 · price: Represents the weighted average share price of an aggregate total of 1,200 shares sold in the price range of $198.84 to $199.63 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $198.26 | $198,257.00 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,976 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 1,000 shares sold in the price range of $197.79 to $198.54 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,000 | $196.92 | $393,846.00 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,976 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $196.60 to $197.46 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 600 | $196.19 | $117,716.40 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,976 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $195.95 to $196.48 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 21:03 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 5,000 | $44.19 | $220,950.00 |
DisclosureSEC source: 0001209191-18-045333 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,576 Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · derivative · entry 7 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 5,000 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 400 | $185.89 | $74,354.00 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · nonDerivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,576 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $185.75 to $186.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,900 | $184.83 | $536,020.05 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,976 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 2,900 shares sold in the price range of $184.50 to $185.38 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,600 | $183.55 | $293,681.44 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,876 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 1,600 shares sold in the price range of $183.315 to $183.980 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 100 | $179.53 | $17,953.00 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,476 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:37 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 5,000 | $44.19 | $220,950.00 |
DisclosureSEC source: 0001209191-18-041258 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,576 Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · derivative · entry 7 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 5,000 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 310 | $184.92 | $57,325.29 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · nonDerivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,576 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F5 · price: Represents the weighted average share price of an aggregate total of 310 shares sold in the price range of $184.91 to $185.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,116 | $184.42 | $205,810.38 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,886 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 1,116 shares sold in the price range of $183.89 to $184.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $183.12 | $183,119.70 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,002 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 1,000 shares sold in the price range of $182.71 to $183.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,574 | $182.30 | $469,242.26 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,002 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 2,574 shares sold in the price range of $181.67 to $182.66 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:31 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 5,000 | $44.19 | $220,950.00 |
DisclosureSEC source: 0001209191-18-035253 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,576 Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:47 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017406 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,576 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2019, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:57 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 247 | $118.33 | $29,227.51 |
DisclosureSEC source: 0001209191-18-015951 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,445 F2 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of the 2017 performance-based restricted stock award that was earned and vested on March 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:57 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015951 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,692 F1 · shares: The reported securities represent shares earned and vested on March 1, 2018 based on achievement of the financial performance conditions for the 2017 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 23:06 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-013138 · doc4.xml · derivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 5,000 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 23:06 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,786 | $131.56 | $234,958.48 |
DisclosureSEC source: 0001209191-18-013138 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 1,786 shares sold in the price range of $131.12 to $132.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 23:06 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,214 | $130.32 | $418,850.73 |
DisclosureSEC source: 0001209191-18-013138 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,768 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 3,214 shares sold in the price range of $130.00 to $130.79 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 23:06 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,000 | $44.19 | $220,950.00 |
DisclosureSEC source: 0001209191-18-013138 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 01:13 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-011639 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,970 Underlying: Common Stock · 5,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 01:13 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,000 | $125.06 | $625,299.50 |
DisclosureSEC source: 0001209191-18-011639 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $125.00 to $125.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 01:13 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,000 | $38.54 | $192,700.00 |
DisclosureSEC source: 0001209191-18-011639 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · derivative · entry 11 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,970 Underlying: Common Stock · 5,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,000 | $120.09 | $600,435.50 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 7 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $120.00 to $120.48 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,000 | $38.54 | $192,700.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · derivative · entry 10 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,970 Underlying: Common Stock · 5,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · derivative · entry 9 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2009. F6 · derivative.expiration_date: Previously filed forms 3 and 4 reported an incorrect expiration date. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 100 | $117.12 | $11,711.50 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,692 | $116.46 | $662,907.40 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 5,692 shares sold in the price range of $116.10 to $117.08 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,208 | $115.74 | $487,033.92 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,774 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 4,208 shares sold in the price range of $115.10 to $116.09 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,000 | $38.54 | $192,700.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 02:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,000 | $0.60 | $3,000.00 |
DisclosureSEC source: 0001209191-18-010569 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 21:03 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049014 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,982 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on September 1, 2018, and 1/16th of which shall vest every three months thereafter on the 1st of the month. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:32 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,765 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-028185 · doc4.xml · derivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,970 Underlying: Common Stock · 9,765 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:32 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 11 | $82.08 | $902.88 |
DisclosureSEC source: 0001209191-17-028185 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:32 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,235 | $81.34 | $344,468.55 |
DisclosureSEC source: 0001209191-17-028185 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,862 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 4,235 shares sold in the price range of $81.0275 to $81.9000 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:32 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,519 | $80.58 | $444,746.96 |
DisclosureSEC source: 0001209191-17-028185 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,097 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 5,519 shares sold in the price range of $80.00 to $80.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:32 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 9,765 | $38.54 | $376,343.10 |
DisclosureSEC source: 0001209191-17-028185 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,339 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-020832 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,735 Underlying: Common Stock · 6,339 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,700 | $75.12 | $127,699.07 |
DisclosureSEC source: 0001209191-17-020832 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 842 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on September 2, 2016. F4 · price: Represents the weighted average share price of an aggregate total of 1,700 shares sold in the price range of $75.00 to $75.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,339 | $75.10 | $476,045.59 |
DisclosureSEC source: 0001209191-17-020832 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 6,339 shares sold in the price range of $75.00 to $75.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,339 | $38.54 | $244,305.06 |
DisclosureSEC source: 0001209191-17-020832 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,426 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · derivative · entry 7 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,074 Underlying: Common Stock · 3,426 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.